About | HyeRang

"2013년에 설립된 혜랑(주)는 ‘Make better treatment available everywhere’라는 비전 아래, 다국적 및 국내 제약사를 대상으로 최적의 컨설팅 솔루션을 제공합니다. 당사는 의약품 허가 및 약가 전략, R&D 전략 수립, 약가 타당성 조사, 시장 조사 등 전방위적인 서비스를 수행하며, 풍부한 업계 경험과 전문성을 바탕으로 고객 맞춤형의 ‘Tailored, Targeted, Timely’ 서비스를 실현하고 있습니다."

Hyerang Co., Ltd.: Your Strategic Partner for Market Access in Korea

Hyerang Co., Ltd. is a specialized consulting firm dedicated to pricing and reimbursement (P&R), empowering pharmaceutical and biotech companies to successfully introduce innovative treatments into the Korean market. Within the complex and dynamic landscape of the Korean healthcare system, we go beyond simple information delivery to provide precise, data-driven analysis and practical reimbursement strategies. We design the entire reimbursement process to ensure your product’s clinical value is rightfully recognized and reaches patients as quickly as possible—from market analysis and pricing feasibility studies to the development of price scenarios and strategic roadmaps for successful reimbursement.

Hyerang Co., Ltd. is committed to becoming your most trusted strategic partner for market access.

Company Core Value

Expertise: In-depth understanding of the Korean Reimbursement & pricing systems
Insight: Data-driven Feasibility analysis and price scenarios
Execution: Strategic gap analysis to proactively mitigate risks and provision of practical, actionable roadmaps.
Partnership: Proven market access solutions built upon a track record of successful case studies.

Who We Are

Rangrhee Jung

CEO, Senior Consultant, Pharmacist, MSPH

Health and Policy Administration, Public Health, UNC, Chapel Hill
Nycomed/Takeda Korea, Market Access Director
Lilly Korea, Market Access Manager
Boryung Pharm, Regulatory Affair/BD Team Leader
Yakup Newspaper, Monthly magazine, Assistant Editor
Bukwang Pharm, Regulatory Affairs & Marketing
Sunkyunkwan Univ. School of Pharmacy

Experience Matters

• 30+ years combined experiences (Pharma + Consulting)

• Hands-on involvement across full product life cycle

- Planning, licensing, regulatory, clinical, pricing & reimbursement

• Proven track record with regulatory, market access success